Sandra J. Horning
305 works · 29,026 citations · h-index 74
Top works
- Revised Response Criteria for Malignant Lymphoma
- Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
- A Prognostic Score for Advanced Hodgkin's Disease
- The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas
- Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients
- Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
- Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
- Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.
- Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon
- Female Reproductive Potential after Treatment for Hodgkin's Disease
- Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis.
- Natural history of and therapy for the indolent non-Hodgkin's lymphomas.
- Clinical and Immunologic Effects of Recombinant Leukocyte A Interferon in Eight Patients With Advanced Cancer
- Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy
- DETECTION OF B-CELL LYMPHOMA IN PERIPHERAL BLOOD BY DNA HYBRIDISATION
- Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.
- Age-related loss of trabecular bone in premenopausal women: A biopsy study
- Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin's Disease: Mature Results of a Prospective Clinical Trial
- Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
- High-Dose Therapy and Autologous Hematopoietic Progenitor Cell Transplantation for Recurrent or Refractory Hodgkin's Disease: Analysis of the Stanford University Results and Prognostic Indices